Ireland· IE-PA-EU/1/11/709/002

BUCCOLAM 5 mg oromucosal solution

A midazolam product containing midazolam, registered in Ireland by Laboratorios Lesvi, S.L.. The same ATC class is registered in 14 of our 19 countries.

ATC N05CD08

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about midazolamAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Midazolam is registered in 14 of 19 countries.

Countries holding a registration under ATC N05CD08 (midazolam), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search midazolam products by name

Midazolam · ATC N05CD08

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of midazolam costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.55 in Switzerland to $16.47 in Spain — a ×30 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Midazolam · price per daily dose (5 mg)

USD · FX 28 Sept 2026

ES Spain$16.47
FI Finland$4.74
CH Switzerland$0.55

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Midazolam
Manufacturer: Laboratorios Lesvi, S.L.
Country: Ireland (IE)
ATC code: N05CD08
ATC class: Midazolam
Defined daily dose: 5 mg, N
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/11/709/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for midazolam.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check midazolam against other medicines How interaction checks work

Midazolam · interactions on record

316 records

9 severe
156 moderate
34 minor
57 info

Most severe, free to view

KetoconazoleH02CA03severe
KetoconazoleJ02AB02severe
FluconazoleJ02AC01severe
Darunavir and cobicistatJ05AR14severe

60 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Midazolam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All midazolam products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Dormicum, Epistatus
Belgium · Midazolam Accord Healthcare, Midazolam Aguettant
Bulgaria · Midazolam Kalceks, Мидазолам Хамелн
Cyprus · Midazolam Accord, Midazolam B. Braun
Czechia · Dormicum, Midazolam Accord
Germany · Dormicum, Dormicum V
Denmark · Epistatus, Midazolam "hameln"
Estonia · Midazolam Kalceks
Spain · Dormicum, Midazolam Accord
Finland · Dormicum, Epistatus
France · Hypnovel, Midazolam Accord
United Kingdom (Northern Ireland) · Hypnovel, Midazolam Accord Healthcare
Greece · Dormicum, Dormipnol
Croatia · Dormicum, Midazolam B. Braun
Hungary · Dormicum, Epistatus
Iceland · Buccolam, Midazolam Accord
Italy · Epistatus, Midazolam Accord Healthcare
Liechtenstein · Buccolam
Lithuania · Fulsed, Midazolam B. Braun
Luxembourg · Midazolam Aguettant, Midazolam B. Braun
Latvia · Fulsed, Midazolam B. Braun
Malta · Midazolam Bp Accord Healthcare, Miprosed
Netherlands · Dormicum, Midazolam Accord
Norway · Buccolam, Epistatus
Poland · Dormicum, Epistatus
Portugal · Dormicum, Midazolam Accord
Romania · Midazolam Desitin, Midazolam Hameln
Sweden · Epistatus, Midazolam Accord
Slovenia · Dormicum, Epistatus
Slovakia · Midazolam Accord, Midazolam Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bf373492-2cb1-48ba-a1aa-68be9fc5bc21
GET /v1/drugs/bf373492-2cb1-48ba-a1aa-68be9fc5bc21?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oromucosal solution",
  "routes": [
    "Oromucosal use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05CD",
    "N05CD08"
  ],
  "strength": null,
  "pa_number": "EU/1/11/709/002",
  "substances": [
    "Midazolam"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "26/10/2011",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about midazolam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console